2. 您的位置
3. 首页
4. 会议论文
5. Molecular Imaging of Mesenchymal Epithelial Transition Receptor (c-Met)Expression Using a Novel 18F-

Molecular Imaging of Mesenchymal Epithelial Transition Receptor (c-Met)Expression Using a Novel 18F-

来源 :2016年长三角药物化学研讨会 | 被引量 : 0次 | 上传用户：zenme123

【摘 要】

：

The mesenchymal epithelial transition factor (c-Met) is a member of the tyrosine kinase growth factor receptor family.Apart from controlling cell migration and growth in embryogenesis,c-Met can contro

【作 者】

：

Kaijun Geng Zhen Cheng Ao Zhang 

【机 构】

：

CAS Key Laboratory of Receptor Research and Synthetic Organic & Medicinal Chemistry Laboratory (SOMC

【出 处】

：

2016年长三角药物化学研讨会

【发表日期】

：

2016年11期

【关键词】

：

c-Met cancer probe fluorination 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　The mesenchymal epithelial transition factor (c-Met) is a member of the tyrosine kinase growth factor receptor family.Apart from controlling cell migration and growth in embryogenesis,c-Met can control growth,invasion,motility and metastasis in cancer cells as well[1,2].

其他文献

Theoretical Simulation of Electronic Circular Dichroism Spectroscopy and Optical Rotations of Chaeto

会议

Development and Structural Modification of BACE1 Inhibitors

会议

Analysis of binding interactions between scutellarein methyl derivatives and bovine serum albumin us

Scutellarin (1) was readily hydrolyzed into scutellarein (2) in the intestine and then metabolited into methylated,sulfated or glucuronidated forms.

会议

Protective effect of 6-O-methyi-Scutellarein on repeatedly cerebral ischemia/reperfusion in rats

6-O-methyl-scutellarein (Figure 1),as the main metabolite of scutellarin (Figure 1) in vivo,has not been reported about its protective effects.

会议

scutellarin6-O-methyl-scutellareincerebral ischemiaBCCAO

Pharmacophore Model and Molecular Dynamics Simulations of Histone deacetylase Inhibitors

Histone deacetylases (HDAC) enzyme plays a significant role in transcriptional regulation by modifying the core histones of the nucleosome,therefore it has emerged as an important therapeutic target f

会议

Histone Deacetylase InhibitorsPharmacophoreMolecular Dynamics SimulationDrug

Synthesis of liguzinediol acetyl amino acid ester prodrugs and their biological evaluation as promis

The liguzinediol was a potential drug for the treatment of heart failure with high effect and low safety risk.However,in vivo pharmacokinetic study showed elimination half-life (t1/2) was too short,ac

会议

liguzinediolprodrugphysicochemical propertiesbioconversionpharmacokinetic

Structure and characterization of the first form of liguzinediol

Liguzineiol has been recently discovered as a potential agent for treatment of heart failure with low safety risk.In this manuscript,we have undertaken a systematic exploration of the liguzinediol pol

会议

liguzinediolcrystal structureX-ray powder diffractionsingle-crystal

2-硫代喹唑啉二酮类衍生物的设计、合成以及抗肿瘤活性研究

会议

Discovery of novel inhibitors disrupting HIF-1α/von Hippel-Lindau interaction through shape-based sc

Major research efforts have been devoted to the discovery and development of compounds that inhibit the protein-protein interaction between HIF-1α and the von Hippel-Lindau protein (pVHL),the substrat

会议

HIF-1 αpVHLshape-based screeningcascade dockingstroke

Cell-surface GRP78 in Cancer Therapy: Drug Discovery by Affinity Selection/Mass Spectrometry (ASMS)

会议